Synopsis
The updated second edition of this popular pocket guide includes newly available and FDA-approved drugs as well as guidance on using the growing number of drugs now prescribed for off-label purposes, such as anti-VEGF agents used in cancer treatments.
"synopsis" may belong to another edition of this title.
From the Back Cover
The updated edition of this popular pocket guide includes new drugs available and FDA-approved since publication of the first edition and also guidance on using the growing number of drugs now prescribed for off-label purposes, such as anti-VEGF agents, used in cancer treatments, which are also being used to stop cell growth in age-related macular degeneration. Drugs are grouped by presenting disease (e.g., glaucoma, retinal disease, cataracts), and readers may also access information via the Product Index or the Subject Index. The entire book is presented in a table format to facilitate quick look-up.
About the Author
Douglas J. Rhee, MD Assistant Professor Harvard Medical School Associate Chief, Practice Development Massachusetts Eye & Ear Infirmary Boston, Massachusetts USA Katheryn A. Colby, MD, PhD Assistant Professor Harvard Medical School Cornea Service Massachusetts Eye & Ear Infirmary Boston, Massachusetts USA Christopher J. Rapuano, MD Professor Jefferson Medical College Director, Cornea Service Wills Eye Hospital Philadelphia, Pennsylvania USA Lucia Sobrin, MD, MPH Assistant Professor Harvard Medical School Massachusetts Eye & Ear Infirmary Boston, Massachusetts USA
"About this title" may belong to another edition of this title.
